Jason Springer

2.8k total citations
37 papers, 481 citations indexed

About

Jason Springer is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, Jason Springer has authored 37 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 18 papers in Rheumatology and 10 papers in Genetics. Recurrent topics in Jason Springer's work include Vasculitis and related conditions (29 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers) and Urticaria and Related Conditions (7 papers). Jason Springer is often cited by papers focused on Vasculitis and related conditions (29 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers) and Urticaria and Related Conditions (7 papers). Jason Springer collaborates with scholars based in United States, Canada and Italy. Jason Springer's co-authors include Alexandra Villa‐Forte, Carol A. Langford, Gary S. Hoffman, Kevin Byram, Soumya Chatterjee, Peter A. Merkel, Peter C. Grayson, Benjamin Nutter, Antoine G. Sreih and Mehrdad Maz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

Jason Springer

35 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Springer United States 14 312 206 105 92 71 37 481
Kimberly Morishita Canada 12 153 0.5× 100 0.5× 130 1.2× 37 0.4× 88 1.2× 27 506
GSRSNK Naidu India 13 222 0.7× 166 0.8× 66 0.6× 60 0.7× 72 1.0× 66 493
T. Quéméneur France 13 408 1.3× 326 1.6× 102 1.0× 154 1.7× 61 0.9× 41 638
Pamela Lutalo United Kingdom 9 161 0.5× 143 0.7× 129 1.2× 35 0.4× 23 0.3× 15 355
Natasha Dehghan Canada 7 251 0.8× 164 0.8× 58 0.6× 99 1.1× 57 0.8× 21 378
Takahiko Kurasawa Japan 13 106 0.3× 290 1.4× 95 0.9× 92 1.0× 44 0.6× 28 424
L H Noël France 11 256 0.8× 63 0.3× 96 0.9× 71 0.8× 54 0.8× 18 605
RA Watts United Kingdom 8 314 1.0× 176 0.9× 92 0.9× 60 0.7× 44 0.6× 27 394
Juyoung Yoo South Korea 12 194 0.6× 170 0.8× 73 0.7× 44 0.5× 34 0.5× 33 319
Belén Atienza‐Mateo Spain 15 302 1.0× 271 1.3× 118 1.1× 51 0.6× 38 0.5× 50 552

Countries citing papers authored by Jason Springer

Since Specialization
Citations

This map shows the geographic impact of Jason Springer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Springer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Springer more than expected).

Fields of papers citing papers by Jason Springer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Springer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Springer. The network helps show where Jason Springer may publish in the future.

Co-authorship network of co-authors of Jason Springer

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Springer. A scholar is included among the top collaborators of Jason Springer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Springer. Jason Springer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corty, Robert W., James Brogan, Kevin Byram, et al.. (2024). VEXAS‐Defining UBA1 Somatic Variants in 245,368 Diverse Individuals in the NIH All Of Us Cohort. Arthritis & Rheumatology. 76(6). 942–948. 15 indexed citations
2.
Springer, Jason & Alexandra Villa‐Forte. (2023). Vasculitis Mimics and Other Related Conditions. Rheumatic Disease Clinics of North America. 49(3). 617–631.
3.
Springer, Jason & Tanaz A. Kermani. (2023). Recent advances in the treatment of giant cell arteritis. Best Practice & Research Clinical Rheumatology. 37(1). 101830–101830. 6 indexed citations
4.
Geetha, Duvuru, Anisha B. Dua, Huibin Yue, et al.. (2023). Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial. Annals of the Rheumatic Diseases. 83(2). 223–232. 30 indexed citations
5.
Springer, Jason, Tanaz A. Kermani, Antoine G. Sreih, et al.. (2022). Self-Reported Data and Physician-Reported Data in Patients With Eosinophilic Granulomatosis With Polyangiitis: Comparative Analysis. SHILAP Revista de lepidopterología. 11(1). e27273–e27273. 4 indexed citations
6.
Springer, Jason, et al.. (2022). Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica. Rheumatic Disease Clinics of North America. 48(2). 493–506. 2 indexed citations
7.
Springer, Jason, et al.. (2022). Diagnostic and Therapeutic Challenges of Vasculitis. Canadian Journal of Cardiology. 38(5). 623–633. 3 indexed citations
8.
Springer, Jason, Mohamad A. Kalot, Nedaa Husainat, et al.. (2021). Granulomatosis With Polyangiitis and Microscopic Polyangiitis: A Systematic Review and Meta‐Analysis of Benefits and Harms of Common Treatments. ACR Open Rheumatology. 3(3). 196–205. 10 indexed citations
9.
Springer, Jason & Ryan S. Funk. (2021). Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis. The Journal of Rheumatology. 48(11). 1718–1724. 3 indexed citations
10.
Springer, Jason, et al.. (2021). Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica. Medical Clinics of North America. 105(2). 311–324. 4 indexed citations
11.
Springer, Jason, et al.. (2020). The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency. Current Rheumatology Reports. 22(10). 64–64. 30 indexed citations
12.
Springer, Jason, et al.. (2020). Clinical Characteristics of an Internet-Based Cohort of Patient-Reported Diagnosis of Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Observational Study. Journal of Medical Internet Research. 22(7). e17231–e17231. 11 indexed citations
14.
Springer, Jason, Paul A. Monach, David Cuthbertson, et al.. (2018). Serum S100 Proteins as a Marker of Disease Activity in Large Vessel Vasculitis. JCR Journal of Clinical Rheumatology. 24(7). 393–395. 18 indexed citations
15.
Springer, Jason, et al.. (2017). Protective Role of Mast Cells in Primary Systemic Vasculitis: A Perspective. Frontiers in Immunology. 8. 990–990. 6 indexed citations
16.
Springer, Jason, Richard A. Prayson, Daniel A. Culver, et al.. (2017). Intra cranial granulomatous disease in common variable immunodeficiency: Case series and review of the literature. Seminars in Arthritis and Rheumatism. 47(6). 890–896. 19 indexed citations
17.
Sreih, Antoine G., Narender Annapureddy, Jason Springer, et al.. (2016). Development and validation of case‐finding algorithms for the identification of patients with anti‐neutrophil cytoplasmic antibody‐associated vasculitis in large healthcare administrative databases. Pharmacoepidemiology and Drug Safety. 25(12). 1368–1374. 30 indexed citations
18.
Springer, Jason, Benjamin Nutter, Carol A. Langford, Gary S. Hoffman, & Alexandra Villa‐Forte. (2014). Granulomatosis With Polyangiitis (Wegener’s). Medicine. 93(2). 82–90. 36 indexed citations
19.
Springer, Jason & Alexandra Villa‐Forte. (2012). Thrombosis in vasculitis. Current Opinion in Rheumatology. 25(1). 19–25. 53 indexed citations
20.
Springer, Jason & Soumya Chatterjee. (2011). Candida albicans Prosthetic Shoulder Joint Infection in a Patient With Rheumatoid Arthritis on Multidrug Therapy. JCR Journal of Clinical Rheumatology. 18(1). 52–53. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026